Global Microbial Fermentation Technology Market Size To Worth USD 56.9 Billion by 2033 | CAGR of 5.7%
SPHERICAL INSIGHTS LLP
7 min read
SPHERICAL INSIGHTS LLP
The Global Microbial Fermentation Technology Market Size Was Valued at USD 32.6 Billion in 2023 and the Worldwide Microbial Fermentation Technology Market Size is Expected to Reach USD 56.9 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: BIOZEEN, TerraVia Holdings, Inc., Planted, Aurisco Pharmaceutical, Koninklijke DSM NV, F. Hoffmann-La Roche AG, Danone, BioVectra Inc., Biocon Ltd., United Breweries Ltd., Amyris, DSM, Biocatalysts, Bluestem Biosciences, Zero Acre Farms, and Other Key Vendors.
New York, United States , Sept. 10, 2024 (GLOBE NEWSWIRE) -- TheGlobal Microbial Fermentation Technology MarketSize is to Grow from USD 32.6 Billion in 2023 to USD 56.9 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.7% during the projected period.
The term "microbial fermentation technology" refers to the biological conversion of elements using microorganisms such as bacteria, yeast, or fungi to produce usable products. Fermentation is a type of biology that occurs in a controlled environment where bacteria, yeast, or other microbes break down sugar or other compounds to produce valuable products such as biofuels, enzymes, pharmaceuticals, and food. Biofuel production will require enzymes, which are chemical catalysts. Fermentation is most commonly used in the food industry, where it is essential for increasing the production of yogurt, beer, and bread. Microbial infections (bacterial and fungal) are a serious problem in respiratory, urinary, surgical, gastrointestinal, and bloodstream infections, which range from mild to severe. The prevalence of infectious diseases has contributed significantly to the spread of antimicrobial products such as antibiotics and vaccines to treat infections, resulting in global market growth. Microorganisms such as Salmonella and Mycobacterium bovis BCG are used in vaccine production, and after fermentation, they become easier to cultivate. The market for microbial fermentation technology is expected to grow in tandem with rising antibiotic demand and the development of new, high-efficiency drugs. However, the high costs of equipment, raw materials, and processing, combined with limited funding and expertise, stymie fermentation market growth, particularly in developing countries.
Browse key industry insights spread across 235 pages with 110 Market data tables and figures & charts from the report on the "Global Microbial Fermentation Technology Market Size, Share, and COVID-19 Impact Analysis, By Application (Antibiotics, Probiotics Supplements, Monoclonal Antibodies, Recombinant Proteins, Biosimilars, Vaccines, Enzymes, Small Molecules, and Others),By End-user (Bio-Pharmaceutical Companies, Contract Research Organizations (CROs), CMOs & CDMOs, and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033."
The antibiotics segment dominates the market with the highest market share of the global microbial fermentation technology market during the projected period. Based on the application, the global microbial fermentation technology market is divided into antibiotics, probiotics supplements, monoclonal antibodies, recombinant proteins, biosimilars, vaccines, enzymes, small molecules, and others. Among these, the antibiotics segment dominates the market with the highest market share of the membrane separation technology market during the projected period. The segment's strong authority is a direct result of the high Patrick, listed as a pro, during a period of increased microbial metabolite research, and the introduction of antibiotics into the market. It wants to know that antibiotics are produced by a living organism through a fermentation process.
The CMOs & CDMOs segment is anticipated to grow at the fastest pace during the projected timeframe. Based on the end user, the global microbial fermentation technology market is categorized into bio-pharmaceutical companies, contract research organizations (CROs), CMOs & CDMOs, and academic & research institutes. Among these, the CMOs & CDMOs segment is anticipated to grow at the fastest pace during the projected timeframe. CMOs and CDMOs are quickly becoming the preferred option for biotherapeutics manufacturers, as the majority of bioprocess innovation is accomplished by smaller firms with limited capacity, trained professionals, and product commercialization resources. A constantly expanding clinical pipeline of biologics is also expected to help drive the segment's growth.
Asia Pacific is expected to hold the largest share of the global microbial fermentation technology market over the forecast period.
Asia Pacific is expected to hold the largest share of the global microbial fermentation technology market over the forecast period. This is because Asia Pacific countries have been recognized as a center for biopharmaceutical outsourcing. Asia Pacific companies, both domestic and international, are expected to construct roughly half of the world's new bioprocessing plants.
North America is predicted to grow at the fastest pace in the global microbial fermentation technology market during the projected period. This is due to companies' increased involvement in biologics research and product development, as well as the presence of numerous contract development organizations in the region. A strong regulatory framework is another important factor influencing the North American market. The US FDA is working to improve guidelines for biopharmaceutical product promotion, development, approval, and legal practice.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the global microbial fermentation technology market are BIOZEEN, TerraVia Holdings, Inc., Novozymes A/S, Lonza, Koninklijke DSM NV, F. Hoffmann-La Roche AG, Danone, BioVectra Inc., Biocon Ltd., United Breweries Ltd., Amyris, Vivici, Biocatalysts, Bluestem Biosciences, Zero Acre Farms, and Others.
In March 2024, Planted, a Swiss plant-based meat startup, invested millions of dollars in fermentation capabilities, creating 30 new jobs at its manufacturing plant in Kemptthal, Switzerland, as it ramps up production of its latest product, a plant-based beef fillet steak.
Market Segment This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global microbial fermentation technology market based on the below-mentioned segments:
Global Microbial Fermentation Technology Market, By Application
Antibiotics
Probiotics Supplements
Monoclonal Antibodies
Recombinant Proteins
Biosimilars
Vaccines
Enzymes
Small Molecules
Others
Global Microbial Fermentation Technology Market, By End-user
Bio-Pharmaceutical Companies
Contract Research Organizations (CROs)
CMOs & CDMOs
Academic & Research Institutes
Global Microbial Fermentation Technology Market, By Regional Analysis
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Rest of Asia Pacific
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of the Middle East & Africa
Browse Related Reports
Global Burn Care Market Size, Share, and COVID-19 Impact Analysis, By Product (Advanced Dressing, Biologics, Traditional Burn Care Products, and Others), By Depth of Burn (Minor Burns, Partial Thickness Burns, Full Thickness Burns), By Cause (Thermal Burns, Electrical Burns, Radiation Burns, Chemical Burns, Friction Burns), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Global Diabetes Associated Ophthalmic Treatment Market Size, Share, and COVID-19 Impact Analysis, By Type (Devices, Drugs), By Application (Glaucoma, Diabetic Retinopathy, Eye Allergy & Infection, Dry Eye Syndrome, Diabetic Associated Macular Degeneration, Cataract, Uveitis), By End-Use (Ambulatory Surgical Centers, Hospitals, and Ophthalmic Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Global Dentures Market Size, Share, and COVID-19 Impact Analysis, By Material (Acrylic Dentures, Flexible Dentures, Ceramic Dentures, Metal Dentures), By Type (Complete, Partial), By End-Use (Hospitals, Dental Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033.
Global Biohacking Market Size, Share, and COVID-19 Impact Analysis, By Product (Supplements, Wearables, Smart Drugs, and Implants (Chips)), By Application (Genetic Engineering, Diagnosis and Treatment, Drug Testing, and Forensic Science), By End-Use (Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, and Hospitals & Clinics), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
About the Spherical Insights & Consulting
Spherical Insights& Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
